These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 14982826)
61. Bronchiolitis obliterans following lung transplantation. Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283 [TBL] [Abstract][Full Text] [Related]
62. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476 [TBL] [Abstract][Full Text] [Related]
63. Bronchiolitis obliterans after lung transplantation: high-resolution CT findings in 15 patients. Worthy SA; Park CS; Kim JS; Müller NL AJR Am J Roentgenol; 1997 Sep; 169(3):673-7. PubMed ID: 9275875 [TBL] [Abstract][Full Text] [Related]
64. Trust Your Instincts. Surgical Lung Biopsy with Normal Chest Imaging in a 49-Year-Old Man with Progressive Dyspnea. O'Beirne SL; Legasto AC; Narula N; Gelbman BD Ann Am Thorac Soc; 2016 May; 13(5):741-5. PubMed ID: 27144798 [No Abstract] [Full Text] [Related]
65. Matrix metalloproteinases and bronchiolitis obliterans: Wrapping the enigma in a riddle. Denlinger CE J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1203-4. PubMed ID: 25618413 [No Abstract] [Full Text] [Related]
66. Methylprednisolone intravenous pulse therapy for pediatric patients with post-infectious bronchiolitis obliterans: an update. Tomikawa SO; Rodrigues JC; Nakaie CMA; Silva Filho LVRFD J Bras Pneumol; 2024 May; 50(2):e20230373. PubMed ID: 38747815 [No Abstract] [Full Text] [Related]
67. Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease. Streiler C; Shaikh F; Davis C; Abhyankar S; Brownback KR Bone Marrow Transplant; 2020 Jun; 55(6):1194-1196. PubMed ID: 31484991 [No Abstract] [Full Text] [Related]
70. [Interventional bronchoscopic treatment for post-infectious bronchitis obliterans]. Guo R; Zhai J; Zou YX; Wang XL; Bi Y Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):374-376. PubMed ID: 38527510 [TBL] [Abstract][Full Text] [Related]
71. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909 [TBL] [Abstract][Full Text] [Related]
72. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039 [TBL] [Abstract][Full Text] [Related]
73. Azithromycin and bronchiolitis obliterans. Kanazawa S; Nomura S; Muramatsu M; Yamaguchi K; Fukuhara S Am J Respir Crit Care Med; 2004 Mar; 169(5):654-5; author reply 655. PubMed ID: 14982826 [No Abstract] [Full Text] [Related]
74. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648 [TBL] [Abstract][Full Text] [Related]
75. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151 [TBL] [Abstract][Full Text] [Related]
76. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151 [TBL] [Abstract][Full Text] [Related]